Drug intelligence / Profile preview

heparin sodium (bovine source)

Development stage
Unknown
Lead developer
Changshan Biochemical Pharmaceutical
Administration
Intravenous, Subcutaneous
01

Overview

Heparin sodium (bovine source) is an unfractionated heparin (UFH) anticoagulant developed and manufactured by Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (HBCS Bio). Extracted from bovine intestinal mucosa or lung, this sulfated glycosaminoglycan acts as a biologic drug that potentiates the activity of antithrombin III (ATIII). This complex subsequently inhibits thrombin (Factor IIa) and Factor Xa, effectively preventing the formation of fibrin clots. It is indicated for the prevention and treatment of various thromboembolic disorders, including deep vein thrombosis (DVT), pulmonary embolism (PE), and acute coronary syndrome, as well as for anticoagulation during surgical procedures and hemodialysis. Notably, the bovine-sourced product is Halal certified, catering to specific global market requirements.

Other names
Bovine heparinUnfractionated heparin (bovine)Bovine source heparin sodium
02

Targets

ATIII (Antithrombin III)Factor XIaFXIIa (Coagulation Factor XIIa)F2 (Thrombin)Coagulation Factor IXaPLG (Plasminogen)F10 (Factor Xa)

Beyond the preview

Go deeper on heparin sodium (bovine source).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on heparin sodium (bovine source).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call